Company intelligence / Profile preview

Celsius42

Eschweiler, North Rhine-Westphalia, Germanycelsius42.de ↗

Ownership: Private
Development stage: Commercial

Overview

The company's hyperthermia systems are commercially available and used in clinical practice to enhance the effectiveness of chemotherapy and radiotherapy for cancer patients. Clinical results indicate improved quality of life and treatment outcomes when used as an adjunct to standard therapies with minimal side effects.

Therapeutic areas: Oncology
Modalities: Device (hyperthermia system)Non-pharmacological therapy (hyperthermia)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

TCS

Commercial

Indications: Cancer

Partnerships

Lootah Group (strategic alliance for Middle East/Africa/India expansion)

Beyond the preview

Go deeper on Celsius42.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celsius42.

Explore the full profile